Crystalline VAP-1 and uses thereof

Details for Australian Patent Application No. 2004241060 (hide)

Owner Biotie Therapies Corp.

Inventors Nyronen, Tommi; Pihlavisto, Marjo; Kidron, Heidi; Airenne, Tomi; Soderholm, Annu; Pentikainen, Olli; Viitanen, Lenita; Johnson, Mark; NymalmRejstrom, Yvonne; Salminen, Tiina; Smith, David

Agent Ahearn Fox

Pub. Number AU-B-2004241060

PCT Pub. Number WO2004/104191

Priority 20030786 26.05.03 FI; 20040271 20.02.04 FI

Filing date 25 May 2004

Wipo publication date 2 December 2004

Acceptance publication date 23 July 2009

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2004/104191 Priority application(s): WO2004/104191

26 March 2009 Alteration of Name

  The name of the applicant has been altered to Biotie Therapies Corp.

23 July 2009 Application Accepted

  Published as AU-B-2004241060

19 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004241069-Methods and compositions for the prevention and treatment of sepsis

2004241039-Highly compatible and non-migratory polymeric UV-absorber